235 related articles for article (PubMed ID: 23034783)
1. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
[TBL] [Abstract][Full Text] [Related]
2. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
[TBL] [Abstract][Full Text] [Related]
3. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
4. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
Deutschbein T; Broecker-Preuss M; Flitsch J; Jaeger A; Althoff R; Walz MK; Mann K; Petersenn S
Eur J Endocrinol; 2012 Apr; 166(4):613-8. PubMed ID: 22214924
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
6. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
[TBL] [Abstract][Full Text] [Related]
7. Stimulated Salivary Cortisol as a Noninvasive Diagnostic Tool for Adrenal Insufficiency.
Kim YJ; Kim JH; Hong AR; Park KS; Kim SW; Shin CS; Kim SY
Endocrinol Metab (Seoul); 2020 Sep; 35(3):628-635. PubMed ID: 32981305
[TBL] [Abstract][Full Text] [Related]
8. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
[TBL] [Abstract][Full Text] [Related]
9. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
10. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.
Raff H
J Clin Endocrinol Metab; 2009 Oct; 94(10):3647-55. PubMed ID: 19602555
[TBL] [Abstract][Full Text] [Related]
11. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
Gow R; Koren G; Rieder M; Van Uum S
Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
[TBL] [Abstract][Full Text] [Related]
12. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
[TBL] [Abstract][Full Text] [Related]
13. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
Arlt W; Rosenthal C; Hahner S; Allolio B
Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
[TBL] [Abstract][Full Text] [Related]
14. Monitoring adrenal insufficiency through salivary steroids: a pilot study.
Tucci L; Fanelli F; Improta I; Bissi V; Lena C; Galante G; Mezzullo M; Magagnoli M; Lalumera AB; Colombin G; Coscia K; Rotolo L; Vicennati V; Pagotto U; Di Dalmazi G
Eur J Endocrinol; 2024 Mar; 190(4):327-337. PubMed ID: 38571387
[TBL] [Abstract][Full Text] [Related]
15. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.
Galbois A; Rudler M; Massard J; Fulla Y; Bennani A; Bonnefont-Rousselot D; Thibault V; Reignier S; Bourrier A; Poynard T; Thabut D
J Hepatol; 2010 Jun; 52(6):839-45. PubMed ID: 20385427
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of salivary cortisol in end stage renal disease.
Arregger AL; Cardoso EM; Tumilasci O; Contreras LN
Steroids; 2008 Jan; 73(1):77-82. PubMed ID: 17945323
[TBL] [Abstract][Full Text] [Related]
17. Salivary cortisol and cortisone in the clinical setting.
Blair J; Adaway J; Keevil B; Ross R
Curr Opin Endocrinol Diabetes Obes; 2017 Jun; 24(3):161-168. PubMed ID: 28375882
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test.
Deutschbein T; Unger N; Mann K; Petersenn S
Eur J Endocrinol; 2009 Jan; 160(1):9-16. PubMed ID: 18952762
[TBL] [Abstract][Full Text] [Related]
19. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
20. Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency.
Frigerio S; Carosi G; Ferrante E; Sala E; Polledri E; Fustinoni S; Ambrosi B; Chiodini I; Mantovani G; Morelli V; Arosio M
Front Endocrinol (Lausanne); 2023; 14():1093838. PubMed ID: 36761196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
